arrow
K

Katharina Sahm

University of Heidelberg
H指数:10
被引数:341

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy and bevacizumab in newly-diagnosed glioblastoma: expansion of the phase I/II GLORIA trial

基于L-RNA适配体的CXCL12抑制联合放射治疗和贝伐珠单抗在 newly-diagnosed glioblastoma 中的研究:扩展I/II期GLORIA试验

2026-04-080
OA
Advanced imaging, immune profiling and nanoparticle immunotherapy distribution in H3K27M-mutated Diffuse Midline Glioma models: identifying and translating MRI signatures

高级成像、免疫图谱和纳米颗粒免疫疗法在H3K27M突变弥漫性中线胶质瘤模型中的分布:识别和转化MRI特征

2025-11-010
OAAI
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial

新诊断的胶质母细胞瘤中基于l-rna适体的CXCL12抑制联合放疗: I/II期GLORIA试验的剂量递增

2024-05-285
OAAI
Concurrent gliomas in patients with multiple sclerosis
2023-12-181
OAAI
INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomas
2023-10-192
OAAI
A H3K27M-targeted vaccine in adults with diffuse midline glioma
2023-09-2126
OAAI
In vivo nanoparticle-based T cell imaging can predict therapy response towards adoptive T cell therapy in experimental glioma
2023-01-018
OAAI